GENUARDI, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 1.854
EU - Europa 1.316
AS - Asia 454
AF - Africa 23
SA - Sud America 6
OC - Oceania 4
Totale 3.657
Nazione #
US - Stati Uniti d'America 1.830
IT - Italia 467
CN - Cina 257
SE - Svezia 175
IE - Irlanda 141
AT - Austria 132
FR - Francia 78
DE - Germania 60
SG - Singapore 58
DK - Danimarca 52
FI - Finlandia 50
UA - Ucraina 49
IN - India 35
GB - Regno Unito 32
JP - Giappone 27
VN - Vietnam 24
CA - Canada 21
KR - Corea 21
SN - Senegal 21
BE - Belgio 15
NL - Olanda 15
PL - Polonia 15
RU - Federazione Russa 11
GR - Grecia 8
HK - Hong Kong 8
UZ - Uzbekistan 7
ES - Italia 6
CH - Svizzera 4
IR - Iran 4
AU - Australia 3
BR - Brasile 3
PK - Pakistan 3
SA - Arabia Saudita 3
TR - Turchia 3
CZ - Repubblica Ceca 2
PR - Porto Rico 2
AR - Argentina 1
CI - Costa d'Avorio 1
CL - Cile 1
CU - Cuba 1
GH - Ghana 1
IL - Israele 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
RO - Romania 1
RS - Serbia 1
VE - Venezuela 1
Totale 3.657
Città #
Chandler 310
Dublin 140
Ashburn 134
Beijing 134
Torino 132
Vienna 132
Ann Arbor 117
Fairfield 102
Nyköping 73
Florence 71
Woodbridge 71
Houston 67
Wilmington 66
Turin 63
Dearborn 56
Villeurbanne 46
Medford 39
Seattle 39
Princeton 37
Cambridge 35
Jacksonville 33
San Mateo 31
Fremont 30
Singapore 28
Redwood City 22
Guangzhou 18
Washington 17
Pisa 16
Dong Ket 15
Bologna 13
Brussels 13
Ottawa 13
Boston 11
Hyderabad 11
Shanghai 11
Rome 10
Milan 9
Norwalk 9
Warsaw 9
Boardman 8
Hebei 8
Helsinki 8
Los Angeles 8
Chennai 7
Hangzhou 7
Nanjing 7
Nutley 7
San Diego 7
Chengdu 6
Duncan 6
Munich 6
Philadelphia 6
Tokyo 6
Toronto 6
Wayne 6
Falls Church 5
Ningbo 5
Pune 5
Seoul 5
Dronten 4
Hong Kong 4
Lappeenranta 4
Naples 4
Noto 4
Saint Petersburg 4
San Mauro Torinese 4
Campi Bisenzio 3
Carmagnola 3
Changchun 3
Kunming 3
New York 3
San Francesco 3
San Francisco 3
Shenyang 3
São Paulo 3
Umeå 3
Zhengzhou 3
Amsterdam 2
Assago 2
Baran 2
Berlin 2
Bilbao 2
Bresso 2
Chicago 2
Cocconato 2
Coimbatore 2
Collegeville 2
Des Moines 2
Edinburgh 2
Flero 2
Flushing 2
Harringay 2
Hefei 2
Jinan 2
Karachi 2
Landshut 2
Lausanne 2
Lille 2
Lonate Pozzolo 2
London 2
Totale 2.419
Nome #
HashClone: a new tool to quantify the minimal residual disease in B-cell lymphoma from deep sequencing data 377
Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program 269
Highly sensitive MYD88 l265p mutation detection by droplet digital polymerase chain reaction in waldenström macroglobulinemia 189
Centralized Biobanking Supports Hematology Clinical Trials: the new challenge of the University of Torino 179
Applying data warehousing to a phase III clinical trial from the Fondazione Italiana Linfomi (FIL) ensures superior data quality and improved assessment of clinical outcomes. 125
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartment. 123
New Molecular Technologies for Minimal Residual Disease Evaluation in B-Cell Lymphoid Malignancies 123
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing 116
TELOMERES SHORTEN DURING CHRONIC LYMPHOCYTIC LEUKEMIA(CLL) EVOLUTION: AN ANALYSIS ON 88 CASES 112
Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis 105
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma 100
Progressive Telomere Shortening Is Part of the Natural History of Chronic Lymphocytic Leukemia (CLL) and Impacts Clinical Outcom 99
Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCR 96
MYD88L265P MUTATION DETECTION IN WALDENSTRÖM MACROGLOBULINEMIA BY DROPLET DIGITAL PCR: MINIMAL RESIDUAL DISEASE MONITORING AND CHARACTERIZATION ON CIRCULATING FREE DNA 95
Delphi, a Data Warehouse to Discover Associations between Variables in Clinical Trials: Application to the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial 95
PROGRESSIVE TELOMERE SHORTENING DURING THE NATURAL HISTORY OF CHRONIC LYMPHOCYTIC LEUKEMIA 92
Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics' impact on survival 90
Telomere lenght measurement in the clinically oriented research setting: a comparison between Southern blot (SB), real time quantitative PCR (RQ-PCR) and FLOW-FISH (FF) 87
Telomere length is an independent predictor of survival, treatment requirement and Richter’s syndrome transformation in chronic lymphocytic leukemia 87
Progressive telomere shortening occurs during the natural history of chronic lymphocytic leukemia (CLL) and associates to outcome 85
Expression of telomeric proteins in chronic lymphocytic leukemia (CLL) 84
The Engineered MIPI (e-MIPI), a Candidate Data-Mining Based Mantle Cell Lymphoma Prognostic Index Developed from the Dataset of the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial 83
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: Evidences from long term follow-up 77
Comparison of two real-time quantitative polymerase chain reaction strategies for minimal residual disease evaluation in lymphoproliferative disorders: correlation between immunoglobulin gene mutation load and real-time quantitative polymerase chain reaction performance. 74
Comparison of different DNA extraction methods from peripheral blood cells: advices from the Fondazione Italiana Linfomi - MRD Network. 74
Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network 72
Minimal Residual Disease in Indolent Lymphomas: A Critical Assessment 69
Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia 68
null 64
Application of the Euro Clonality next-generation sequencing-based marker screening approach to detect immunoglobulin heavy chain rearrangements in mantle cell lymphoma patients: first data from the Fondazione Italiana Linfomi MCL0208 trial 60
Clinical implications and prognostic role of minimal residual disease detection in follicular lymphoma 57
Droplet digital PCR quantification of mantle cell lymphoma follow-up samples from four prospective trials of the european MCL network 50
Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma 46
Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase III trial in mantle cell lymphoma 41
MYD88L265P Detection in IgM Monoclonal Gammopathies: Methodological Considerations for Routine Implementation 39
Dissecting MRD Kinetics By Automated Computational Analysis to Improve Outcome Prediction in Mantle Cell Lymphoma: A Bioinformatic Substudy from the Fondazione Italiana Linfomi (FIL) MCL0208 Clinical Trial 38
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma 38
A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial 30
Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network 25
MODULATION OF THE IMMUNE MICROENVIROMENT IN MULTIPLE MYELOMA PATIENTS TREATED WITH DARATUMUMABBASED THERAPY: TUMOR CELL-EXTRINSIC EFFECTS OF DARATUMUMAB TREATMENT 20
Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphoma. 17
Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial 11
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma 9
Totale 3.790
Categoria #
all - tutte 11.852
article - articoli 0
book - libri 0
conference - conferenze 2.742
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.594


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020553 0 9 18 73 40 64 67 56 41 51 59 75
2020/2021551 75 49 56 29 38 27 29 33 47 37 67 64
2021/2022622 19 15 15 47 36 27 83 39 15 84 150 92
2022/2023909 92 107 18 101 59 215 57 67 91 27 35 40
2023/2024439 68 86 35 27 27 63 12 32 1 21 18 49
2024/202527 22 5 0 0 0 0 0 0 0 0 0 0
Totale 3.790